2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs 

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2819
  



  

  
Submitter : 
  

  
Mr. John Rolf
  

  
Date & Time: 
  

  
02/16/2006 04:02:26
  



  

  
Organization : 
  

  
n/a
  



  

  
Category : 
  

  
Federal Government
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Wyeth's attempt denie women the choice of bio-identical hormone treatment is un-American.  Furthermore, it is a transparent attempt to protect their inferior drug treatment's market share.  If the FDA plans to get in bed with the pharma industry on this issue, there will vast outcry by both men and women.  We demand that the FDA stand up for women's right to chose the best treatment option for themselves.